ClinicalTrials.Veeva

Menu
C

Clinica de Pesquisas e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda | Sao Paulo, Brazil

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BBO-10203
Estrogen

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study (ELCIN)

The purpose of this study is to evaluate the efficacy and safety of elacestrant over the course of 6 months in patients with estrogen receptor positi...

Active, not recruiting
Metastatic Breast Cancer
Drug: Elacestrant

First in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with...

Enrolling
Metastatic Colorectal Cancer
Solid Tumor, Adult
Drug: Ribociclib
Drug: BBO-10203

Trial sponsors

Stemline Therapeutics logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems